Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 4-(1H-imidazol-5-yl)-1H-pyrrolo[2, 3-b] pyridines for use in the treatment of leukaemias, lymphomas and solid tumors

4-(1H-imidazol-5-yl)-1H-pyrrolo[2, 3-b] pyridines for use in the treatment of leukaemias, lymphomas and solid tumors

US Patent 11498920 · Granted Nov 15, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted aminothiazoles as inhibitors of nucleases2023
Substituted propanamides as inhibitors of nucleases2022
Pyrazolotriazines as inhibitors of nucleases2018
Furopyridines as inhibitors of protein kinases2018
Furopyridines as inhibitors of protein kinases2018
Method of determination of diagnosis and prognosis in patients with B-cell chron2015
Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors2014
Modulators of cell cycle checkpoints and their use in combination with checkpoin2013
Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors2013
Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors2013
Methods for inhibiting protein kinases2012
N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors2010